Review: Danon disease: Review of natural history and recent advances

G. Cenacchi, V. Papa, V. Pegoraro, R. Marozzo, M. Fanin, C. Angelini

Research output: Contribution to journalReview article

Abstract

Danon disease is a severe multisystem disorder clinically characterized by hypertrophic cardiomyopathy, skeletal myopathy and mental retardation in male patients, and by a milder phenotype (predominantly involving cardiac muscle) in female patients. The disease is inherited as an X-linked dominant trait. The primary deficiency of lysosome-associated membrane protein-2 (LAMP-2) causes disruption of autophagy, leading to an impaired fusion of lysosomes to autophagosomes and biogenesis of lysosomes. We surveyed over 500 Danon disease patients reported in the literature from the first description to the present, in order to summarize the clinical, pathological and molecular data and treatment perspectives. An early molecular diagnosis is of crucial importance for genetic counselling and for therapeutic interventions: in male patients, the prognosis is poor due to rapid progression towards heart failure, and only heart transplantation modifies the disease course.

Original languageEnglish
JournalNeuropathology and Applied Neurobiology
DOIs
Publication statusAccepted/In press - Jan 1 2019

Keywords

  • Danon disease
  • hypertrophic cardiomyopathy
  • LAMP-2
  • vacuolar myopathy
  • Wolff–Parkinson–White syndrome

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology
  • Neurology
  • Clinical Neurology
  • Physiology (medical)

Cite this

Review : Danon disease: Review of natural history and recent advances. / Cenacchi, G.; Papa, V.; Pegoraro, V.; Marozzo, R.; Fanin, M.; Angelini, C.

In: Neuropathology and Applied Neurobiology, 01.01.2019.

Research output: Contribution to journalReview article

@article{e09ba828c27a433aaa0dc32fcc976114,
title = "Review: Danon disease: Review of natural history and recent advances",
abstract = "Danon disease is a severe multisystem disorder clinically characterized by hypertrophic cardiomyopathy, skeletal myopathy and mental retardation in male patients, and by a milder phenotype (predominantly involving cardiac muscle) in female patients. The disease is inherited as an X-linked dominant trait. The primary deficiency of lysosome-associated membrane protein-2 (LAMP-2) causes disruption of autophagy, leading to an impaired fusion of lysosomes to autophagosomes and biogenesis of lysosomes. We surveyed over 500 Danon disease patients reported in the literature from the first description to the present, in order to summarize the clinical, pathological and molecular data and treatment perspectives. An early molecular diagnosis is of crucial importance for genetic counselling and for therapeutic interventions: in male patients, the prognosis is poor due to rapid progression towards heart failure, and only heart transplantation modifies the disease course.",
keywords = "Danon disease, hypertrophic cardiomyopathy, LAMP-2, vacuolar myopathy, Wolff–Parkinson–White syndrome",
author = "G. Cenacchi and V. Papa and V. Pegoraro and R. Marozzo and M. Fanin and C. Angelini",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/nan.12587",
language = "English",
journal = "Neuropathology and Applied Neurobiology",
issn = "0305-1846",
publisher = "Wiley Blackwell",

}

TY - JOUR

T1 - Review

T2 - Danon disease: Review of natural history and recent advances

AU - Cenacchi, G.

AU - Papa, V.

AU - Pegoraro, V.

AU - Marozzo, R.

AU - Fanin, M.

AU - Angelini, C.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Danon disease is a severe multisystem disorder clinically characterized by hypertrophic cardiomyopathy, skeletal myopathy and mental retardation in male patients, and by a milder phenotype (predominantly involving cardiac muscle) in female patients. The disease is inherited as an X-linked dominant trait. The primary deficiency of lysosome-associated membrane protein-2 (LAMP-2) causes disruption of autophagy, leading to an impaired fusion of lysosomes to autophagosomes and biogenesis of lysosomes. We surveyed over 500 Danon disease patients reported in the literature from the first description to the present, in order to summarize the clinical, pathological and molecular data and treatment perspectives. An early molecular diagnosis is of crucial importance for genetic counselling and for therapeutic interventions: in male patients, the prognosis is poor due to rapid progression towards heart failure, and only heart transplantation modifies the disease course.

AB - Danon disease is a severe multisystem disorder clinically characterized by hypertrophic cardiomyopathy, skeletal myopathy and mental retardation in male patients, and by a milder phenotype (predominantly involving cardiac muscle) in female patients. The disease is inherited as an X-linked dominant trait. The primary deficiency of lysosome-associated membrane protein-2 (LAMP-2) causes disruption of autophagy, leading to an impaired fusion of lysosomes to autophagosomes and biogenesis of lysosomes. We surveyed over 500 Danon disease patients reported in the literature from the first description to the present, in order to summarize the clinical, pathological and molecular data and treatment perspectives. An early molecular diagnosis is of crucial importance for genetic counselling and for therapeutic interventions: in male patients, the prognosis is poor due to rapid progression towards heart failure, and only heart transplantation modifies the disease course.

KW - Danon disease

KW - hypertrophic cardiomyopathy

KW - LAMP-2

KW - vacuolar myopathy

KW - Wolff–Parkinson–White syndrome

UR - http://www.scopus.com/inward/record.url?scp=85075458938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075458938&partnerID=8YFLogxK

U2 - 10.1111/nan.12587

DO - 10.1111/nan.12587

M3 - Review article

C2 - 31698507

AN - SCOPUS:85075458938

JO - Neuropathology and Applied Neurobiology

JF - Neuropathology and Applied Neurobiology

SN - 0305-1846

ER -